Reimagining the future of healthcare

ASHLEY / Huntington’s Disease Community Advocate

Ashley, Huntington’s Disease Community Advocate

Press Releases

Aug 15, 2024
uniQure Announces Dosing of First Patient in Phase I/IIa Clinical Trial of AMT-191 for the Treatment of Fabry Disease
Aug 1, 2024
uniQure Announces Second Quarter 2024 Financial Results and Provides Company Update
Jul 23, 2024
uniQure Announces Closing of Sale of Manufacturing Facility to Genezen

See All